Calidi Biotherapeutics (CLDWW) Q4 2025 Earnings

13NovConfirmed
Q4 2024
Q2 2025
Q3 2025
Q4 2025
-2.21
-1.69
-1.17
-0.65

Details

Expected EPS
-1.68
Actual EPS
-2.21
Surprise EPS
-0.53
Surprise Percent
+31.55%

Description

Calidi Biotherapeutics (CLDWW) has reported earnings of -2.21 per share for Q4 2025.

0 Comments

Share your thoughts